The capsid (CA) sequence of human immunodeficiency virus type 1 (HIV-1) Gag protein consists of two independently folded domains named the N-terminal domain (NTD) and C-terminal domain (CTD) that are connected by a flexible linker. Most of the CTD sequence adopts rigid structure except for the last 11 amino acids (positions 354 to 364) that are disordered even in the context of the downstream SP1 and nucleocapsid (NC) sequence. Although disordered, this short peptide region plays a crucial role in HIV-1 replication. In this study, we identified three secondsite mutations within Gag named A238T, G358S, and N373K that rescued a deleterious mutation R362A located at the C-terminus of CA. A238T is located within the NTD of CA, G358S and N373K are positioned proximal to R362A. One of the mechanisms underlying this compensation event is correction of reduced packaging of viral RNA into the R362A mutated viruses, as shown by the results of RNase protection assays, native Northern blots experiments as well as filter-binding assays. These data suggest that one potential function for the C-terminal disordered sequence of CA in HIV-1 replication is to regulate HIV-1 RNA packaging. D
Introduction
Human immunodeficiency virus type 1 (HIV-1) encodes the Gag protein that is capable of forming virus-like particles in the absence of other viral proteins (Gheysen et al., 1989) . During or shortly after virus budding from cells, Gag is cleaved by viral protease to generate mature and infectious viruses. Proteolysis of Gag leads to the production of matrix (MA), capsid (CA), nucleocapsid (NC), p6, as well as two short spacer peptides termed SP1 and SP2. MA forms a thin layer underneath virus envelope, while CA constructs the shell of the conical core in which NC associates with viral genomic RNA (Freed, 1998) .
An important role of MA is to target Gag to cellular membranes where Gag assembles. This activity is attributed to the N-terminal sequence of MA that consists of two structural elements, including the myristyl moiety covalently linked to the second glycine as well as the multiple basic residues of the first 31-amino-acid region. These two motifs are defined as the membrane-binding domain (Gottlinger et al., 1989; Mervis et al., 1988; Spearman et al., 1994; Zhou et al., 1994) . The myristyl group anchors Gag into the lipid bilayer, whereas the downstream basic residues further stabilize Gag-membrane association via electrostatic interaction with the negatively charged phosphor groups of the membrane lipids.
CA is capable of self-association and generates regular geometric structures exhibiting a hexagonal lattice pattern (Ganser et al., 1999; Li et al., 2000) . Of the two independently folded CA domains, the N-terminal domain forms the hexameric rings, and the C-terminal domain links one ring to its six neighbors. This property of CA not only underlies the generation of the mature core but may also guide the Gag precursor to produce the immature capsid structure (Mayo et al., 2002 (Mayo et al., , 2003 . In this sense, CA regulates spatial arrangement of Gag within virion.
NC is a highly basic protein featured by two CCHC zinc finger motifs. In the context of the Gag precursor, NC recruits two copies of viral genomic RNA into each virus particle (Berkowitz et al., 1996) . These two RNA molecules, noncovalently linked at their 5V ends as a dimer, in turn serve as a scaffold for Gag aggregation (Burniston et al., 1999; Campbell and Rein, 1999; Campbell and Vogt, 1995; Cimarelli et al., 2000; Khorchid et al., 2002; Sandefur et al., 2000; Zhang et al., 1998) . This scaffold activity of viral genomic RNA can be executed by non-viral RNA species (Muriaux et al., 2001) .
P6 is located at the C-terminus of Gag and plays vital roles in virus budding (Gottlinger et al., 1991; Huang et al., 1995) . This region harbors two short motifs, i.e., P(T/S)AP and LXXLF, that bind to cellular proteins TSG101 (tumor susceptibility gene 101) and AIP1, respectively (Garrus et al., 2001; MartinSerrano et al., 2001; Strack et al., 2003; VerPlank et al., 2001; von Schwedler et al., 2003) . These two cellular proteins recruit factors that are involved in vacuolar protein sorting to the sites of virus assembly and together catalyze budding and release of virus particles from cellular membranes. The relevant motifs of p6 are named late budding domain (Freed, 2002) .
Importance of the aforementioned Gag domains in virus production is further manifested by successive construction of a Gag derivative containing minimal Gag sequences that suffice to produce virus-like particles (Accola et al., 2000) . This minimal Gag construct comprises the first seven amino acids of MA and the C-terminal domain of CA, SP1, NC, and p6, of which NC and p6 can be changed to heterogeneous sequences without impeding virus production. For example, NC can be replaced either by the leucine zipper sequence from the yeast transcription factor GCN4 or by the Bacillus subtilis MtrB protein domain (Accola et al., 2000; Zhang and Barklis, 1997) . Similarly, p6 can be changed to different types of late domain such as PPPY from Rous sarcoma virus (Accola et al., 2000) . These results together implicate the indispensable role for the C-terminal domain of CA and SP1 in generation of virus-like particles.
The C-terminal domain of CA contains four helices that fold into a globular structure appended by a disordered fragment consisting of the last 11 amino acids (positions 354 to 364) (Gamble et al., 1997; Newman et al., 2004; Worthylake et al., 1999) . Regardless of its disordered structure, 8 out of these 11 amino acids have been shown to be vital for virus particle production Melamed et al., 2004) . To gain insight into the underlying mechanisms, we have studied the R362A mutation located within this disordered region, and we successfully identified three second-site mutations within Gag named A238T, G358S, and N373K that rescued R362A. Results of further studies revealed that one major mechanism underlying this compensation event involved restoration of wild-type RNA packaging to the R362A mutated virus.
Results
The R362A mutation is rescued by the A238T, G358S, and N373K second-site mutations The R362A mutation is located at the C-terminus of CA and has been shown to inhibit virus replication .
In the present study, we have cultured the R362A mutant in MT-2 cells until the virus regained wild-type infectivity. Sequencing analysis of proviral DNA from the reverted virus indicated retention of the R362A mutation as well as emergence of three second-site mutations within Gag, i.e., A238T, G358S, and N373K (Fig. 1A) . The A238T mutation is located within the NTD of CA and participates in formation of helix 5. G358S belongs to the 355-GGPG-358 motif and is four amino acids upstream of R362A. N373K resides within SP1 and is eleven residues downstream of R362A (Fig. 1A) .
To test whether these three second-site mutations can rescue R362A, they were inserted into the R362A HIV-1 cDNA clone to generate a series of recombinant DNA constructs (Fig. 1B) . Both wild-type and mutated HIV-1 cDNA were transfected into COS-7 cells, and virus particles thus generated were used to infect MT-2 cells. The results in Fig. 1B show that levels of RT activity in culture fluids peaked at day 6 for wild-type BH10. In contrast, the R362A mutant generated detectable levels of RT activity only by day 16 post-infection. Each of the A238T, G358S, and N373K mutations markedly stimulated growth of virus R362A, although A238T enhanced viral replication to a lesser extent than either G358S or N373K (Fig. 1B) . The three second-site mutations together restored wild-type replication capacity to R362A (Fig. 1B) . We further measured infectivity of the aforementioned viruses in single-round infection through performing MAGI assays (Kimpton and Emerman, 1992) . The R362A mutation decreased virus infectivity by approximately threefold; this defect was corrected to wild-type levels in the presence of the second-site mutations A238T, G358S, and N373K (Fig. 1C) . It is noticed that the extent of reduction in virus infectivity measured for the R362A mutant in the MAGI assays is less pronounced than the replication defect observed in infected MT-2 cells. This is likely because the results of MAGI assays reflect the level of Tat protein produced by infected virus, whereas replication curves are a measurement of virus yield following infection. Overall, these results show that A238T, G358S, and N373K suffice to restore wild-type infectivity to the R362A mutant.
The A238T, G358S, and N373K second-site mutations enhance particle production of the R362A virus Results of our previous studies showed that the R362A mutation caused three to fourfold decrease in virus particle production upon transfection of viral cDNA into COS-7 cells . These data were reproduced in transfection experiments by measuring levels of either viral p24 (CA) or reverse transcriptase (RT) that was associated with extracellular virus particles ( Fig. 2A) . This defect partially accounts for diminished infectivity of the R362A virus. Consistent with their rescuing activity, the A238T, G358S, and N373K second-site mutations together increased yield of the R362A mutated virus particles to wild-type levels, as shown by the results of Western blots and ELISA ( Fig. 2A) . When virus particles were examined with electron microscopy, lower numbers of virus particles were seen for the R362A mutant as compared with the wild-type and the A238T/G358S/N373K/R362A recombinant virus. In addition, the R362A mutated virus particles contained electron-dense cores that frequently assumed acentric position and barely exhibited conical shape (Fig. 2B) . Thus, the R362A mutation not just diminishes the yield of virus particles but also moderately affects the core structure.
The R362A virus packages lower levels of viral genomic RNA It is noted that the N373K suppressor mutation, located 11 amino acids downstream of R362A, introduces a basic residue into the SP1 region. This observation suggests importance of 4 HeLa-CD4-LTR-h-gal cells were exposed to the mutated or wild-type viruses equivalent to 10 ng of p24(CA) for 48 h before the numbers of blue cells were scored. The results shown are from one infection experiment. The relative infectivity between viruses is consistent in three infection studies that were performed with virus stocks obtained from different transfection experiments. were measured with Western blots or ELISA using anti-HIV-1 p24 (CA) antibody. Levels of virion-associated reverse transcriptase (RT) were either determined in Western blots using anti-HIV-1 RT antibody or by measuring RT activity. Relative levels of virus particles generated by each DNA construct were calculated on the basis of ELISA data and levels of RT activity with those of the wild-type BH10 set as 100. (C) Observation of virus particles with transmission electron microscopy. Transfected COS-7 cells were processed following the procedure for electron microscopy. Particles with electron-dense cores are shown for the wild-type BH10 as well as the A238T/G358S/N373K/R362A and R362A mutated viruses. The bar represents a scale of 200 nm. More than 60 particles from each type of viruses were examined to determine core position as well as core shape.
basic charge for the function of the R362 residue, and that this function may relate to Gag -RNA interaction and viral RNA packaging considering the close proximity of R362 and N373 to the downstream NC region. To test this hypothesis, viral RNA was extracted from either the mutated or wild-type virus particles followed by analysis in an RNase protection assay (Fig. 3A) . The results of Fig. 3B show that levels of viral genomic RNA incorporated into the R362A mutated virus particles were three to fourfold less than those for the wild-type BH10. This viral RNA packaging defect is not attributed to altered viral RNA expression within cells, since comparable levels of full length and spliced viral RNA were detected within either R362A-or BH10-transfected cells (Fig. 3B) . When A238T, G358S, and N373K were combined with R362A, viral RNA packaging was corrected to wild-type levels (Fig. 3B) . It is noted that combinations A238T/N373K and G358S/N373K exerted a more potent effect in this regard than A238T/G358S. Therefore, N373K contributes to the largest extent among these three suppressor mutations in fixing defective viral RNA packaging; nonetheless, the optimal compensation effect can only be achieved when all three mutations are present.
To validate the aforementioned observation, we measured levels of viral RNA within the R362A mutated viruses through performing native Northern blots experiment. Viral RNA was prepared from mutated or wild-type virus particles equivalent to 150 ng HIV-1 p24 (CA) and separated on native agarose gels. Results of Northern blots using labeled HIV-1 DNA probes revealed markedly diminished levels of viral RNA associated with the R362A mutated viruses as compared with wild-type BH10. An approximately fourfold reduction in packaging of the R362A viral RNA was calculated on the basis of RNA band intensity from the results of three Fig. 3 . Effect of the R362A mutation on HIV-1 RNA packaging. (A) Illustration of the HIV-1 RNA probes used in RNase protection assay (Russell et al., 2003) . Sizes of RNA fragments protected for viral genomic RNA and spliced RNA are shown. (B) RNase protection assays to measure viral RNA levels either associated with virus particles or with transfected cells. Results from cell-associated viral RNA are shown for R362A, BH10, and A238T/G358S/N373K/R362A. RNA bands corresponding to the genomic, spliced, and total viral RNA are indicated on the left side of the gels. The band of the probe is shown to indicate its excessive amount used in the experiments. Levels of virion-associated genomic RNA were determined on the basis of relative band intensity as quantified by digital image analysis using the AlphaImager v5.5 program. Results shown are the average from three independent experiments. independent native Northern blots (data not shown), which is consistent with the data obtained in RNase protection assays, and is also reflected by the three to fourfold decrease of virus infectivity shown by the results of MAGI assays (Fig. 1C) . Again, the three second-site mutations together corrected this RNA packaging defect (Fig. 4A) .
Interestingly, the R362A mutated viruses contained only dimeric RNA. When viral RNA was treated at different temperatures prior to separation on native agarose gels, the results showed that the R362A viral RNA dimer displayed the same stability as the wild-type RNA dimer (Fig. 4B) . Therefore, the R362A mutation restricts viral RNA packaging but does not disrupt viral RNA dimerization. This observation implicates that each R362A virus particle always incorporates two copies of viral RNA albeit with low efficiency compared to wild-type virus, and these two viral RNA molecules can be converted to stable RNA dimer when NC is released during virus maturation. It is noted that viral RNA prepared from virus particles dissociated into small RNA fragments following heat treatment at 50 -C or 55 -C. This might be due to the presence of nicks in viral RNA. It remains to be tested whether the R362A mutation has any effect on this RNA fragmentation event.
The R362A attenuates Gag-viral RNA binding
We next studied whether the RNA packaging defect seen for the R362A mutant is a result of decreased Gag -RNA binding. Toward this end, we exploited a Gag derivative termed (mini)Gag to measure the affinity of Gag for viral RNA in filter-binding assays. The (mini)Gag contains the first 2-7 amino acids of MA, the C-terminal domain of CA (amino acids 278 to 364), SP1 (amino acids 365 to 378), and the NC sequence (amino acids 379 to 433) (Roldan et al., 2004) . This Gag version has previously been shown to display high affinity for HIV-1 RNA packaging sequences (Roldan et al., 2004) . We inserted the R362A mutation alone or together with G358S and N373K into (mini)Gag such as to generate (mini)Gag-R362A, (mini)Gag-G358S/R362A, (mini)Gag-N373K/R362A, and (mini)Gag-G358S/N373K/R362A, respectively (Fig. 5A) . The affinity of the wild-type or the mutated (mini)Gag proteins for HIV-1 RNA sequence (nt 223 to 506, containing viral RNA packaging elements SL1 to SL4) was measured in filterbinding assays with PolyI/PolyC as non-specific competitors. On the basis of their K d values (Fig. 5B) , the wild-type (WT) and mutated (mini)Gag proteins are ranked as WT G358S/ N373K/R362A < N373K/R362A < G358S/R362A R362A. This result demonstrates that the R362A mutation diminishes the binding of Gag with HIV-1 RNA packaging signals. The compensatory mutation N373K fixes this defect to approximately wild-type levels, whereas the G358S mutation exerts minor effect in this regard.
Discussion
In this study, we made two major findings. First, attenuated replication of the R362A mutated virus is rescued by the A238T, G358S, and N373K second-site mutations within Gag. Second, the R362A mutation suppresses HIV-1 RNA packaging, and this defect is fixed by the aforementioned compensatory mutations.
R362 is the third amino acid to the C-terminus of CA and represents one of the last 11 amino acids that are disordered in the structures calculated for CA 146 -231 , CA 146 -231 -SP1 and CA (CTD) -SP1-NC (Gag residues 276 to 431) molecules (Momany et al., 1996; Newman et al., 2004; Worthylake et al., 1999) . Interestingly, NMR analysis of a synthetic peptide bearing Gag sequence at amino acid positions 345 to 392 revealed a 23-amino acid a-helix that encompasses the last seven residues of CA, the entire 14 amino acids of SP1, and the first two residues of NC (Morellet et al., 2005) . This latter observation is consistent with the results of computer modeling and genetic analysis (Accola et al., 1998) . It is likely that the CA-SP1-NC junction sequence can either exist in a structurally Fig. 4 . The R362A mutation does not affect dimerization of HIV-1 RNA. (A) Native Northern blots to assess levels of viral RNA dimerization. RNA samples from purified virus particles equivalent to 150 ng p24(CA) were separated on 0.9% agarose gels followed by hybridization with HIV-1 DNA probes. Positions of RNA dimer and monomer are indicated on the left side of the gel. Sizes of RNA markers are also shown. (B) Measuring stability of viral RNA dimers. Viral RNA was first treated at various temperatures (40-, 45-, 50-, and 55 -C) for 10 min in the presence of 100 mM NaCl before being separated on agarose gels. disordered state or adopt regular helix under certain conditions such as Gag binding to RNA. Both features may be required for this region to exert distinct functions at different stages of Gag assembly.
We noted that the G358S and N373K suppressor mutations reside, together with R362A, within the putative a-helix spanning the CA-SP1-NC junctions (Fig. 1A) . More precisely, since G358S is 4 amino acids upstream of R362A and N373K is 11 amino acids downstream of R362A, these three mutated residues are actually positioned on the same side of the helix (Fig. 6 ). According to NMR structures (Morellet et al., 2005) , residues H359, R362, E366, Q370, and N373 together constitute a hydrophilic surface, opposite to a hydrophobic surface involving residues L364, M368, V371, T372, A375, and M378 (Fig. 6) . Predictably, the R362A mutation diminishes the hydrophilic extent of the related surface. By virtue of their sitting on the same helical surface with R362A, the G358S and N373K second-site mutations must have increased the hydrophilic levels to the hydrophilic interface and thus help to reestablish relevant Gag -Gag interactions (Fig. 6) .
HIV-1 RNA packaging involves specific recruitment of viral genomic RNA from the abundant cellular RNA pool into virus particles. This selection process depends on high affinity of NC for viral RNA packaging signals that are located within the 5V untranslated region such as SL2 and SL3, a concept that is well illustrated by the NMR structures calculated for the NC/SL2 and NC/SL3 complexes (Amarasinghe et al., 2000; De Guzman et al., 1998) . Since generation of immature virus particles precedes virus maturation, NC must have acted in the context of the Gag precursor to recognize viral RNA. On the basis of this concept, NC can be assisted by other sequences of Gag when exercising its viral RNA packaging activity. One evidence in support of this view is that the SP1 region has been shown to regulate HIV-1 RNA packaging. For example, a chimeric HIV-1/HIV-2 Gag with HIV-2 MA-CA and HIV-1 SP1-NC-p6 showed higher preference for packaging HIV-1 RNA than Gag chimera containing HIV-2 MA-CA-SP1 and HIV-1 NC-p6 (Kaye and Lever, 1998) . Moreover, the T12I amino acid substitution at the C-terminus of SP1 enabled the SL1-deleted viruses to exclude spliced viral RNA from encapsidation (Russell et al., 2003) . We now show that HIV-1 RNA packaging is restricted by an R362A mutation located at the C-terminus of CA. This latter result does not come as a surprise but rather presents further support for involvement of Alternatively, the inverse of protein concentration was plotted against the inverse of saturation factor (SF) as described (Bailey, 1979) . The K d values were calculated for each type of Gag tested and were used to determine the relative RNA binding affinity. Results shown are for experiments performed at 25 -C. K d value of AM range was calculated when the binding reactions were performed on ice (data not shown). Under both conditions, the wild-type (WT) (mini)Gag displayed a K d value of three to fourfold lower than the (mini)Gag-R362A.
the CA-SP1 putative helix in selective packaging of HIV-1 RNA considering that R362 and the SP1 sequence are both located within the same helical structure.
In contrast to its adverse effect on HIV-1 RNA packaging, the R362A mutation does not disrupt dimerization of HIV-1 RNA (Fig. 4) . The observation that retroviral RNA dimerization can occur in the face of diminished RNA packaging has also been made in other retroviruses such as murine leukemia virus (MLV) (Hibbert et al., 2004; Levin and Rosenak, 1976) . For instance, cellular mRNA molecules containing packaging signals from MLV were incorporated as dimers into virus particles irrespective of the severely diminished packaging efficiency of these chimeric mRNAs compared with MLV genomic RNA (Hibbert et al., 2004) . In addition, treatment of cells with actinomycin D resulted in diminished viral RNA packaging; yet, virion-associated viral genomic RNA was almost entirely dimeric (Levin and Rosenak, 1976) . These results suggest that retroviruses have evolved stringent mechanisms to maintain diploid even when RNA packaging efficiency is compromised.
Conceivably, at least two mechanisms are involved in reinforcing retrovirus diploid: not just that dimerization has to take place prior to packaging, but also that viral RNA dimer must be preferable for packaging than monomer. The first hypothesis is supported by the result of a recent study showing that the palindrome within the dimerization initiation signal was protected from Me 2 SO 4 modification in the context of HIV-1 RNA derived from infected cells (Paillart et al., 2004) , which suggests that this palindrome has paired with its counterpart of a second HIV-1 RNA molecule within cells before viral RNA packaging occurs. The second mechanism is manifested by NMR structures solved for the MLV NC complex with the ''core encapsidation'' RNA fragment (D'Souza and Summers, 2004) . In particular, a short nucleotide stretch ''306-UCUG-309'' was identified to exhibit high affinity for NC (K d = 75 T 12 nM), but was exposed only when two viral RNA molecules formed a dimer, which implicates higher packaging efficiency for dimeric viral RNA than for monomeric ones.
In summary, results of this study demonstrate that the R362A mutation leads to reduction in viral RNA packaging as well as in viral replication. This finding suggests an important hitherto unappreciated role for the CA-SP1 boundary sequence in Gag -RNA interaction. Our data also support the notion that HIV-1 RNA forms premature dimers prior to packaging into virus particles.
Materials and methods

Plasmid DNA construction
The BH10 infectious HIV-1 cDNA clone was employed as starting material to generate the following mutations. The A238T, G358S, and N373K second-site mutations were combined with R362A by PCR through use of the primer pairs A238T-A/Sph-S (5V-GGT ACT AGT AGT TCC TGT TAT GTC ACT TCC-3V/5V-AGT GCA TCC AGT GAT GCA GGG CC-3V), G358S-S/NC-A (5V-GGA GTA GGA GGA CCC AGC CAT AAG GCA GC-3V/5V-TTA GCC TGT CTC TCA GTA CAA TC-3V) and N373K-S (5V-GC CAA GTA ACA AAG TCA GCT ACC ATA ATG-3V)/NC-A, respectively. The mutated nucleotides are underlined in relevant primers. The PCR products resulting from use of A238T/Sph-S were employed as mega primers in a second round of PCR together with the Fig. 6 . Computer modeling to show restoration of the hydrophilic surface where both the R362A mutation as well as the compensatory mutations G358S and N373K are located. Residues comprising the hydrophilic and hydrophobic surfaces are highlighted in blue and red, respectively. Structure of wild-type Gag sequence (positions 345 -392) (Morellet et al., 2005 ) is used to calculate structures for the R362A and G358S/N373K/R362A mutated sequences using ESyPred3D web server (Lambert et al., 2002) .
NC-A anti-sense primer and the R362A DNA construct as template. Similarly, the G358S/NC-A and N373K/NC-A PCR products were used as primers in a second-round PCR together with the Sph-S sense primer. The final PCR products were digested with restriction enzymes SphI and ApaI and inserted into the BH10 DNA construct that had been digested with the same two enzymes. The same strategy was used to geneQ rate DNA constructs such as A238T/G358S/R362A, A238T/ N373K/R362A, G358S/N373K/R362A, and A238T/G358S/ N373K/R362A. DNA clones (mini)Gag, (mini)Gag-R362A, (mini)Gag-G358S/R362A, (mini)Gag-N373K/R362A, and (mini)Gag-G358S/N373K/R362A were created by PCR through use of primer pair (mini)Gag-F/NC-R (5V-CAC CGG TGC GAG AGC GTC AGT AAG CCC TAC CAG CAT TCT GGA C-3V/5V-TTA ATT AGC CTG TCT CTC AGT ACA ATC-3V). The BH10 DNA clones containing the relevant mutations were employed as DNA templates in PCR. Amplified DNA fragments were then inserted into the expression vector Topo 100-D (Invitrogen, Burlington, ON, Canada).
Cell culture, transfection, and infection COS-7 and HeLa cells were grown in Dulbecco's modified Eagle's medium (DMEM) and MT-2 cells in RPMI 1640, supplemented with 10% fetal calf serum. COS-7 cells were transfected using Lipofectamine (Invitrogen) in accordance with the manufacturer's instructions. Virus infection assay was performed through infecting 5 Â 10 5 MT-2 cells in a 2-ml volume using an amount of virus equivalent to 5 ng of p24 (CA). Cells were washed twice 2 h after infection and cultured in 10 ml of complete RPMI 1640 medium. Culture fluids were collected at various times, and reverse transcriptase (RT) activity was measured to monitor virus replication.
Virus infectivity was also measured in multinuclear activation of a galactosidase indicator (MAGI) assay (Kimpton and Emerman, 1992) . HeLa-CD4-LTR-h-gal cells were plated in 24-well plates (2 Â 10 4 cells/well) and infected with an amount of virus equivalent to 10 ng of p24 (CA) per well. Each infection was performed in triplicate. Three independent infections were conducted using virus stocks obtained from independent transfection experiments. Forty-eight hours postinfection, cells were fixed with 1% formaldehyde À0.2% glutaraldehyde in phosphate-buffered saline and stained with 5-bromo-4-chloro-3-indolyl-h-d-galactoside (X-Gal) for 45 min. Infectivity was calculated as the number of blue cells counted per well.
RNase protection assay
The experiments were performed as described previously (Russell et al., 2003) . In brief, HIV-1 RNA probes were internally labeled with [a- 32 P]UTP (ICN) through in vitro transcription of BspE1-linearized RPA1 plasmid DNA using T7-MEGAshortscript kit (Ambion Inc., Austin, Texas, USA). Viral RNA samples that were prepared from purified virus particles equivalent to 25 ng of p24 (CA) incubated at 42 -C overnight with labeled riboprobes (10 5 cpm) followed by digestion with single-strand-specific RNases (RPA II kit, Ambion Inc.). An amount of 250 ng RNA samples from cells transfected with either wild-type BH10, or the mutated R362A and A238T/G358S/N373K/R362A DNA was also assessed. Protected RNA fragments were fractionated on 5% polyacrylamide-8 M urea gels and further visualized by autoradiography. Relative intensity of each band was quantified by digital image analysis using the AlphaImager v5.5 program.
Native Northern blots
The experiments were performed as previously described . In brief, virus particles collected from transfected COS-7 cells were clarified by centrifugation in a Beckman GR-6S centrifuge at 3000 rpm for 30 min at 4 -C, followed by ultracentrifugation through a 20% sucrose cushion in a Beckman XL-80 ultracentrifuge with an SW41 rotor at 40,000 rpm for 1 h at 4 -C. Virus pellets were suspended in 300 Al of Tris (50 mM, pH 7.8) -NaCl (100 mM) buffer and then treated in lysis buffer (50 mM Tris -HCl (pH 7.4), 10 mM EDTA, 1% sodium dodecyl sulfate (SDS), 100 mM NaCl, 50 Ag of yeast tRNA/ml, 100 Ag of proteinase K/ml) for 30 min at 37 -C. Samples were extracted twice with phenol -chloroform -isoamylalcohol (25:24:1) and once with chloroform. Viral RNA was precipitated in 2.5 volumes of 95% ethanol with 0.3 M sodium acetate (pH 5.2). RNA pellets were washed with 70% ethanol and dissolved in Tris (50 mM) -EDTA (10 mM) (pH 7.5) (TE) buffer. An amount of viral RNA equivalent to 150 ng of HIV-1 p24 was fractionated on 0.9% native agarose gels in 1Â Tris -borate-EDTA (TBE) buffer at 100 V for 4 h at 4 -C. Viral RNA was transferred onto nylon membranes and detected through use of HIV-1 DNA probes (nucleotide positions 1 to 2000) internally labeled with [a- 32 P]dCTP (ICN, Irvine, CA, USA). To measure the stability of RNA dimers, viral RNA samples were first incubated at various temperatures such as 40 -C, 45 -C, 50 -C, and 55 -C in a buffer containing 100 mM NaCl prior to electrophoresis on native agarose gels.
Gag purification and filter-binding assays
The His-(mini)Gag contains a 6xHis tag at the N-terminus followed by the first 2 -7 amino acids of MA, the CTD of CA (278 -364), SP1 (365 -378), and NC (379 -433) (Fig. 5A ). This Gag derivative was purified as we described previously (Roldan et al., 2004) . In brief, after transforming E. coli BL21 (DE3), expression of His-(mini)Gag was induced with adding IPTG. Three hours post-induction, the His-(mini)Gag proteins were purified using nickel -nitrilotriacetic acid resin (Qiagen, Mississauga, ON, Canada) in accordance with the manufacturer's instructions. Purified His-(mini)Gag proteins were refolded through dialysis in a buffer containing 0.5 M TrisHCl (pH8.0), 50 mM NaCl, 10 AM ZnCl 2 , 5 mM/0.5 mM reduced/oxidized glutathione, 0.01% CHAPS at 4 -C for 3 h, followed by centrifugation at 57,000 Â g to remove any misfolded or aggregated Gag proteins (Roldan et al., 2004) .
Filter-binding experiments were performed as previously described (Roldan et al., 2004) . HIV-1 RNA sequence (nucleotide positions 223 to 506) was generated through in vitro transcription in the presence of [a- 32 P]UTP (ICN) using the Megashortscript kit (Ambion). Various amounts of purified His-(mini)Gag proteins were incubated with 1 nM radiolabeled probes in a buffer containing10 mM HEPES (pH 7.5), 100 mM KCl, 1 mM MgCl 2 , 0.5 mM EDTA, 10 AM ZnCl 2 , 1 mM dithiothreitol, 20 ng/Al Poly I/Poly C as non-specific competitors, and 7.5% Ficoll. After incubation for 15 min at 25 -C, the samples were filtered through 0.45 AM nitrocellulose disks (Millipore, Nepean, ON, Canada). The filters were washed twice with storage buffer (50 mM Tris (pH 8.0), 50 mM NaCl, 20% glycerol), levels of radioactivity that were retained on the filters were quantified by liquid scintillation counting (Roldan et al., 2004) . The K d values were calculated as described (Bailey, 1979) .
Electron microscopy
Transfected COS-7 cells were fixed with 2.5% glutaraldehyde and further treated with 4% osmium tetroxide. Thin sections of the embedded samples were stained with lead citrate and uranyl acetate and visualized using a JEOL JEM-2000 FX transmission electron microscope equipped with a Gatan 792 Bioscan 1024-by 1024-byte wide-angle multiscan charge-coupled device camera.
